Clinical Trials Directory

Trials / Completed

CompletedNCT02065726

Whey Protein Supplementation in Cancer Patients

Whey Protein Supplementation in Malnourished Cancer Patients: a Randomized, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
166 (actual)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nutritional derangements are very common in cancer patients and negatively affect survival, morbidity and quality of life. Intervention trials have demonstrated that nutritional counseling can improve energy balance, nutritional status and quality of life in patients undergoing chemo-radiotherapy. Oxidative stress plays a role in the tumor-cytotoxic effect of cancer chemotherapy and radiotherapy but may also play a role therapy-related adverse events such as an impairment of nutritional status and quality of life. The nutritional properties of whey protein have recently raised attention. In view of the high content in cysteine these proteins can positively stimulate the synthesis of glutathione which, in turn, could contribute to the modulation of whole-body and cellular redox state. However, evidence on the role of this dietary intervention in cancer patients is limited.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWhey proteinNutritional counseling consists in a personalized dietary prescription and regular (monthly) dietetic advise by a registered dietician + 20 g (2 x 10 g) of whey proteins
OTHERNutritional counselingNutritional counseling consists in a personalized dietary prescription and regular (monthly) dietetic advise by a registered dietician

Timeline

Start date
2014-02-25
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2014-02-19
Last updated
2025-05-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02065726. Inclusion in this directory is not an endorsement.